Psychemedics Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 5.54 million compared to USD 6.51 million a year ago. Net loss was USD 0.726 million compared to USD 0.338 million a year ago. Diluted loss per share from continuing operations was USD 0.13 compared to USD 0.06 a year ago.
For the six months, sales was USD 11.4 million compared to USD 13.02 million a year ago. Net loss was USD 1.11 million compared to USD 0.299 million a year ago. Diluted loss per share from continuing operations was USD 0.19 compared to USD 0.05 a year ago.